We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+1.9%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$809M
AUM Growth
-$221M
Cap. Flow
-$234M
Cap. Flow %
-28.88%
Top 10 Hldgs %
38.79%
Holding
5,677
New
1,365
Increased
1,774
Reduced
1,410
Closed
1,002

Sector Composition

Rank Sector Weight
1 Financials 4.61%
2 Consumer Discretionary 4.23%
3 Healthcare 3.96%
4 Technology 3.11%
5 Energy 3.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VLP
826
DELISTED
Valero Energy Partners LP
VLP
$108K 0.01%
2,239
-3,401
-60% -$165K
ADTN icon
827
Adtran
ADTN
$615M
$107K 0.01%
5,737
+5,316
+1,263% +$113K
FSS icon
828
Federal Signal
FSS
$7.82B
$107K 0.01%
6,812
+5,612
+468% +$87.3K
KRG icon
829
Kite Realty
KRG
$5.36B
$107K 0.01%
3,814
+172
+5% +$4.99K
SRPT icon
830
Sarepta Therapeutics
SRPT
$1.77B
$107K 0.01%
8,045
+7,581
+1,634% +$101K
CUB
831
DELISTED
Cubic Corporation
CUB
$107K 0.01%
+2,063
New +$108K
TIF
832
DELISTED
Tiffany & Co.
TIF
$107K 0.01%
1,218
+1,005
+472% +$89.9K
NE
833
DELISTED
Noble Corporation
NE
$107K 0.01%
7,461
+1,881
+34% +$30.5K
HF
834
DELISTED
HFF Inc.
HF
$107K 0.01%
2,834
+2,307
+438% +$82.9K
TIVO
835
DELISTED
TIVO INC
TIVO
$107K 0.01%
10,062
+8,019
+393% +$86.6K
ENTA icon
836
Enanta Pharmaceuticals
ENTA
$400M
$106K 0.01%
3,447
+3,408
+8,738% +$133K
NI icon
837
NiSource
NI
$20.4B
$106K 0.01%
6,123
+6,077
+13,211% +$103K
LMRK
838
DELISTED
Landmark Infrastructure Partners LP Common Units
LMRK
$106K 0.01%
5,802
+5,000
+623% +$87.1K
PTLA
839
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$106K 0.01%
+2,780
New +$95.5K
BPL
840
DELISTED
Buckeye Partners, L.P.
BPL
$106K 0.01%
1,400
+1,261
+907% +$94.6K
LABL
841
DELISTED
Multi-Color Corp
LABL
$106K 0.01%
+1,524
New +$96.9K
VR
842
DELISTED
Validus Hold Ltd
VR
$106K 0.01%
2,511
+111
+5% +$4.57K
DGX icon
843
Quest Diagnostics
DGX
$26.3B
$105K 0.01%
+1,366
New +$97.8K
MCD icon
844
McDonald's
MCD
$195B
$105K 0.01%
+1,075
New +$102K
NBIX icon
845
Neurocrine Biosciences
NBIX
$16.6B
$105K 0.01%
2,652
+459
+21% +$16.4K
SVU
846
DELISTED
SUPERVALU Inc.
SVU
$105K 0.01%
+1,295
New +$92.9K
FSL
847
DELISTED
FREESCALE SEMICONDUCTOR LTD
FSL
$105K 0.01%
2,569
+2,535
+7,456% +$87.3K
MRH
848
DELISTED
MONTPELIER RE HOLDINGS LTD
MRH
$105K 0.01%
2,723
-127
-4% -$4.59K
ALV icon
849
Autoliv
ALV
$9B
$104K 0.01%
1,228
-775
-39% -$61.4K
GTE icon
850
Gran Tierra Energy
GTE
$317M
$104K 0.01%
3,833
+2,460
+179% +$66.6K

Similar funds

Tower Research Capital (TRC)'s Q1 2015 Portfolio in Review

As of Q1 2015, Tower Research Capital (TRC) held 5,677 positions worth $809M, down 21% from $1.03B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Tower Research Capital (TRC) withdrew a net $234M in Q1 2015, closing 1,002 positions and reducing 1,410 holdings. Its most notable exit was iShares Core S&P Mid-Cap ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 1.9% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in VanEck Semiconductor ETF worth $24.6M.

  • Tower Research Capital (TRC)'s largest Q1 2015 buy was VanEck Semiconductor ETF: 889,360 shares worth $24.6M.
  • Tower Research Capital (TRC) added most to VanEck Gold Miners ETF in Q1 2015, an estimated $21.7M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $252M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q1 2015, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 39% of its $809M portfolio in Q1 2015.
  • Tower Research Capital (TRC) opened 1,365 new positions and closed 1,002 in Q1 2015.
  • Tower Research Capital (TRC)'s portfolio value fell 21% quarter-over-quarter to $809M.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2015, filed 12 May 2015.